(icTV) Interview with Jamie Cooper
In this icTV interview, Jamie Cooper (Melbourne, Australia) reveals results from the TRANSFUSE study, a randomised controlled trial of standard issue transfusion versus fresher red blood cell use in intensive care and he discusses the possible clinical implications of these findings.
The full TRANSFUSE Trial results were presented for the first time at ESICM’s annual congress LIVES 2017 in Vienna.
This presentation at the Hot Topics session at LIVES 2017 will be available on e-LIVES.
Click here to read the related article in NEJM.